Process for reducing contaminating michael acceptor levels in oxycodone and other compositions
AssigneeControlled Chemicals, Inc.
InventorsJules A. Shafer, Vladislav V. Telyatnikov, Hao Wang
Life of this patent
Estimating the term…
Abstract
The present invention relates to processes for removal of Michael acceptors from certain compositions wherein the composition is treated with a thiol-containing compound under conditions sufficient to remove Michael acceptors and the resulting thiol-Michael adducts. Certain embodiments of the present invention enable quantification and/or removal of Michael acceptors and/or Michael acceptor precursors.
Claims17
1-67. (canceled)
A process for preparing a processed composition containing a pharmaceutical agent by removing a Michael acceptor contaminant from a composition containing a pharmaceutical agent to provide a processed composition comprising a reduced Michael acceptor content of less than 200 ppm which may be internalized by a living organism;
- the method comprising the steps of:
- treating the composition containing the Michael acceptor, or salt thereof, with a thiol-containing compound at a thiol and hydrogen ion concentration selected to yield the reduction in Michael acceptor as determined by the equilibrium expression:
- [TM]/[M]=KR[T]t/(1+KSH/[H+])
- wherein [TM] is concentration of thiol-Michael adduct, [M] is the concentration of Michael acceptor, [T]t is the total concentration of thiol-containing compound, [H+] is hydrogen ion concentration, KR is the equilibrium constant for the reaction, KSH is the acid dissociation constant for the thiol-containing compound;
- wherein the thiol-containing compound reacts with at least one Michael acceptor or salt thereof to provide a thiol-Michael adduct or salt thereof;
- and
- separating the resulting thiol-Michael adduct or salt thereof from the composition by one or any combination of selective precipitation or extraction of the composition in order to provide a processed composition comprising a reduced Michael acceptor content of less than 200 ppm which may be internalized by a living organism;
- wherein the Michael acceptor is an α,β-unsaturated carbonyl derivative or an α,β-unsaturated nitrile.
A process for preparing a processed composition containing a pharmaceutical agent by removing a Michael acceptor hydrate contaminant from a composition containing a pharmaceutical agent to provide a processed composition comprising a reduced Michael acceptor content of less than 200 ppm which may be internalized by a living organism;
- the method comprising the steps of:
- converting the Michael acceptor hydrate, or salt thereof, with an acidic catalyst to a Michael acceptor, or salt thereof;
- reacting the composition containing the Michael acceptor, or salt thereof, with a thiol-containing compound at a thiol and hydrogen ion concentration selected to yield the reduction in Michael acceptor as determined by the equilibrium expression:
- [TM]/[M]=KR[T]t/(1+KSH/[H+])
- wherein [TM] is concentration of thiol-Michael adduct, [M] is the concentration of Michael acceptor, [T]t is the total concentration of thiol-containing compound, [H+] is hydrogen ion concentration, KR is the equilibrium constant for the reaction, KSH is the acid dissociation constant for the thiol-containing compound;
- wherein the thiol-containing compound reacts with at least one Michael acceptor or salt thereof to form a thiol-Michael adduct or salt thereof;
- and
- separating the thiol-Michael adduct or salt thereof from the composition by one or any combination of selective precipitation or extraction of the composition in order to provide a processed composition comprising a reduced Michael acceptor content of less than 200 ppm which may be internalized by a living organism;
- wherein the Michael acceptor is an α,β-unsaturated carbonyl derivative or an α,β-unsaturated nitrile.
Dependencies are inferred from the claim text.